Brief: Sinopharm Group Says FY Profit Attributable RMB8.53 Bln
March 27 (Reuters) - Sinopharm Group Co Ltd 1099.HK :
* FY PROFIT ATTRIBUTABLE RMB8.53 BILLION VERSUS RMB7.76
BILLION
* FY REVENUE RMB552.15 BILLION VERSUS RMB521.05 BILLION
* PROPOSE TO DISTRIBUTE A FINAL DIVIDEND OF RMB0.82 PER
SHARE (TAX
INCLUSIVE)
Source text for Eikon: ID:nHKS5zh2j6
Further company coverage: 1099.HK
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For